Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial.
Vivash L, Bertram KL, Malpas CB, Marotta C, Harding IH, Kolbe S, Fielding J, Clough M, Lewis SJG, Tisch S, Evans AH, O'Sullivan JD, Kimber T, Darby D, Churilov L, Law M, Hovens CM, Velakoulis D, O'Brien TJ.
Vivash L, et al.
BMJ Open. 2021 Dec 16;11(12):e055019. doi: 10.1136/bmjopen-2021-055019.
BMJ Open. 2021.
PMID: 34916328
Free PMC article.